Stay updated on Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing Revision: v3.6.5, indicating a minor version update to the page’s template or underlying platform.
    Difference
    0.1%
    Check dated 2026-09-01T19:39:22.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.5, signaling a minor update to the page. This change represents a backend or UI update rather than a modification to study details.
    Difference
    0.1%
    Check dated 2026-08-11T16:22:52.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a small backend/UI update that does not affect the study details or displayed information.
    Difference
    0.1%
    Check dated 2026-07-28T05:23:39.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the page's documentation or rendering.
    Difference
    0.1%
    Check dated 2026-07-06T18:19:05.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Revision tag on the page was updated from v3.6.0 to v3.6.2, indicating a platform revision. The change is purely technical and does not affect the study details displayed on the page.
    Difference
    0.1%
    Check dated 2026-06-29T15:49:41.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was standardized. The page's revision metadata was updated to Revision: v3.6.0, and additional fields such as 'Last verified' and 'Last known status was' appeared.
    Difference
    1%
    Check dated 2026-06-15T08:34:19.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.